Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer, HER2 Negative Primary Tumor

Explore clinical trials studying Metastatic Breast Cancer, HER2 Negative Primary Tumor. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer, HER2 Negative Primary Tumor trial results

Completed

Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.

NCT01975142

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, HER2 Negative Primary Tumor, +4 more
Locations
  • Clinique Victor Hugo Le Mans, France
  • Institut de Cancérologie HARTMANN Levallois-Perret, France
  • Centre Oscar Lambret Lille, France
  • Chu de Limoges Limoges, France
View Trial Details

Related conditions